Detection and imaging of target tissue

• US 20070258908A1
• Filed: 04/27/2007
• Published: 11/08/2007
• Est. Priority Date: 04/27/2006
• Status: Abandoned Application

• Current Assignee: Barnes-Jewish Hospital (BJC Health System)
• Original Assignee: Barnes-Jewish Hospital (BJC Health System)
• Inventors: Lanza, Gregory, Wickline, Samuel
• Application Number:
  US11/796,415
• Publication Number:
  US 20070258908A1
• Time in Patent Office: Days
• US Class Current: 424/9.322
• CPC Class Codes: A61K 49/0041 Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal in vivo G01N
• CPC Class Codes: A61K 49/0082 micelle, e.g. phospholipidic micelle and polymeric micelle
• CPC Class Codes: A61K 49/0093 Nanoparticle, nanocapsule, nanobubble, nanosphere, nanobead, i.e. having a size or diameter smaller than 1 micrometer, e.g. polymeric nanoparticle
• CPC Class Codes: A61K 49/1809 Micelles, e.g. phospholipidic or polymeric micelles
• CPC Class Codes: A61K 51/122 Microemulsions, nanoemulsions

Abstract

Methods for high resolution imaging of a suspected target tissue are encompassed by the invention. Such methods include administering low resolution and high resolution contrast agents specific to targeted cells or tissues. The contrast agents are allowed to bind to the target cells or accumulate in a target tissue. A low resolution imaging technique is used to localize an accumulation of the low resolution contrast agent in a target tissue. A high resolution image of the target tissue is then obtained to localize an accumulation of the higher resolution contrast agent, allowing the generation of a higher resolution image than that obtained by the use of the low resolution contrast agent alone. These methods may utilize nanoparticles optionally in an emulsion as a contrast agent.

Claims

1. A method for high resolution imaging, comprising

a) administering a targeted low resolution contrast agent and a targeted higher resolution contrast agent having an analogous target as the low resolution contrast agent to a subject, and allowing each contrast agent to accumulate in a target tissue;

b) identifying the target tissue using a low resolution imaging technique to localize an accumulation of the low resolution contrast agent; and

c) obtaining a high resolution image of the target tissue using a high resolution imaging technique to localize an accumulation of the higher resolution contrast agent, thereby allowing the generation of a higher resolution image than that obtained by the use of the low resolution contrast agent alone.

2. The method of claim 1, wherein the low resolution contrast agent and the higher resolution contrast agent are the same agent detectable using a low resolution modality and a higher resolution modality.

3. The method of claim 1, wherein a decoy particle is administered with the low resolution contrast agent.

4. The method of claim 1, wherein the low resolution contrast agent and/or higher resolution contrast agent is incorporated into a nanoparticle.

5. The method of claim 4, wherein the low resolution contrast agent and higher resolution contrast agent are incorporated into the same nanoparticle.

6. The method of claim 4, wherein the nanoparticle is contained within an emulsion.

7. The method of claim 6, wherein the emulsion of nanoparticles comprises a liquid halocarbon core surrounded by a lipid coating.

8. The method of claim 1, wherein the low resolution and/or higher resolution contrast agent is targeted by a target-specific ligand.

9. The method of claim 8, wherein the target-specific ligand is an antibody, an antibody fragment, a peptide, an aptamer, a peptide mimetic, a drug or a hormone.

10. A method of delivering targeted contrast agents to a target tissue, which method comprises

a) administering a low resolution targeted contrast agent to a subject comprising a target tissue;

b) administering a higher resolution targeted contrast agent to the subject, wherein the higher resolution contrast agent has an analogous target as the low resolution contrast agent; and

c) allowing the contrast agents to accumulate in the target tissue, to thereby deliver targeted contrast agents to the target tissue.

11. The method of claim 10, wherein the low resolution and/or higher resolution contrast agent is incorporated into a nanoparticle.

12. The method of claim 11, where the low resolution and higher resolution contrast agents are incorporated into the same nanoparticle.

13. The method of claim 11, wherein the nanoparticle is contained within an emulsion.

14. The method of claim 13, wherein the emulsion of nanoparticles comprises a liquid halocarbon core surrounded by a lipid coating.

15. The method of claim 10, further comprising obtaining an image of the targeted tissue bound to the low resolution contrast agent.

16. The method of claim 15, further comprising obtaining a high resolution contrast image of the targeted tissue.

17. The method of claim 10, wherein the target tissue is characterized by high levels of α

_vβ

₃ integrin, and wherein the low resolution and/or higher resolution contrast agent is coupled to a ligand for α

_vβ

₃ integrin.

18. A kit for the preparation of an emulsion of nanoparticles targeted to a tissue expressing a target moiety, which kit comprises at least one container that contains nanoparticles comprising a ligand specific for the target moiety and a linking moiety for coupling to a low resolution contrast agent and/or a higher resolution contrast agent, at least one container that contains the low resolution contrast agent, and at least one container that contains the higher resolution contrast agent.

19. The kit of claim 18, wherein the nanoparticles are halocarbon-based nanoparticles that further comprise a coating of lipid/surfactant.

20. The kit of claim 18, wherein the target moiety is α

_vβ

₃.

21. The kit of claim 18, wherein the higher resolution contrast agent comprises at least one MRI contrast agent.

22. The kit of claim 18, wherein the low resolution contrast agent comprises ^99mTc.

23. A kit for the preparation of an emulsion of nanoparticles targeted to a tissue expressing a target moiety, which kit comprises at least one container that contains nanoparticles comprising a linking moiety for coupling to a ligand specific for the target moiety, at least one container that contains a ligand specific for the target moiety, at least one container that contains a low resolution contrast agent, and at least one container that contains a higher resolution contrast agent.

24. A kit for high resolution imaging, comprising at least one container that contains a targeted low resolution contrast agent, at least one container that contains a higher resolution contrast agent, and instructions means for use.

25. The kit of claim 24, wherein one or both of the contrast agents is targeted to α

_vβ

₃.

26. The kit of claim 25, wherein the high resolution contrast agent is selected from the group consisting of an MRI agent, a CT imaging agent, an optical imaging agent, an ultrasound imaging agent, a paraCEST imaging agent, and a combination thereof.

27. A method to obtain a magnetic resonance image of a target, wherein the higher resolution contrast agent comprises an MRI agent, which method comprises administering the composition of claim 25 to the target;

and obtaining a magnetic resonance image of the target.

28. The method of claim 27, wherein the target is contained in a mammalian subject.

29. The kit of claim 25, wherein one or both of the contrast agents comprise nanoparticles.

30. A kit for high resolution imaging, comprising at least one container that contains halocarbon-based nanoparticles comprising a ligand specific for a target moiety, wherein the nanoparticles are coupled to a higher resolution contrast agent, and instructions means for use.

31. The kit of claim 30, wherein the halocarbon-based nanoparticles comprise PFOB.

32. A method to obtain a high resolution image of a target tissue, wherein the higher resolution contrast agent comprises a MRI contrast agent, which method comprises administering the composition of claim 31 to a subject;

identifying a target tissue using a fluorine MRI to localize an accumulation of the low resolution contrast agent in the target tissue; and

obtaining a magnetic resonance image of the target tissue, thus generating a high resolution image of the target tissue.